A Hybrid Classification Tree and Artificial Neural Network Model for Predicting the In vitro Response of the Human Immunodeficiency Virus (HIV1) to Anti-Viral Drug … WR Danter, D Gregson, KA Ferguson, MR Danter, J Bend Artificial Neural Networks in Medicine and Biology: Proceedings of the …, 2000 | | 2000 |
A novel artificial lung organoid for simulating a patient derived adenocarcinoma of lung for personalized oncology S Esmail, WR Danter medRxiv, 2021.04. 20.21255803, 2021 | 2 | 2021 |
Abstract A25: COTI-2, a novel small molecule that is effective against multiple human cancer cell lines in vitro and in vivo KY Salim, SM Vareki, WR Danter, J Koropatnick Clinical Cancer Research 23 (1_Supplement), A25-A25, 2017 | 1 | 2017 |
Advancing Drug Development with aiHumanoid Simulations: A Virtual Phase 1 Comparative Study of Standard Chemotherapy versus Standard Chemotherapy plus COTI-2 for Pancreatic … WR Danter medRxiv, 2023.09. 08.23295256, 2023 | 2 | 2023 |
AI-Guided Discovery of Novel SARS-CoV-2 PLpro Inhibitors: Accelerating Antiviral Drug Development in the Fight Against COVID-19 W Spagnoli, WR Danter bioRxiv, 2023.04. 05.535700, 2023 | | 2023 |
An aiHumanoid Simulation of Gram-Negative Sepsis: A Comprehensive Multi-Organoid Platform for Advanced Disease Modeling, Drug Discovery, and Personalized Medicine. W Danter bioRxiv, 2023.07. 18.549304, 2023 | 2 | 2023 |
Artificial neural network prediction of survival or death following admission to ICU WR Danter, T Wood, NJ Morrison Clin Invest Med 19, S14, 1996 | 8 | 1996 |
ARTIFICIAL NEURAL-NETWORK CATEGORIZATION OF CARDIAC EJECTION FRACTION BASED ON ECHOCARDIOGRAPHIC DATA WR DANTER, KJ YVORCHUK, KL CHAN CIRCULATION 92 (8), 3507-3507, 1995 | | 1995 |
ARTIFICIAL NEURAL-NETWORK PREDICTION OF THE PRESENCE OR ABSENCE OF RENAL-ARTERY STENOSIS IN HYPERTENSIVE PATIENTS UNDERGOING ISOTOPE RENOGRAPHY TJ CARR, WR DANTER, TS EAKINS RADIOLOGY 197, 215-215, 1995 | | 1995 |
Artificially induced pluripotent stem cell-derived whole-brain organoid for modelling the pathophysiology of metachromatic leukodystrophy and drug repurposing S Esmail, WR Danter Biomedicines 9 (4), 440, 2021 | 10 | 2021 |
Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre | 5 | 2015 |
Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,367,675, 2013 | 11 | 2013 |
Compounds and method for treatment of cancer WR Danter, CKK Lau US Patent 8,466,151, 2013 | 8 | 2013 |
Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,822,475, 2014 | 1 | 2014 |
Compounds and method for treatment of cancer WR Danter, CK Lau US Patent 8,895,556, 2014 | 3 | 2014 |
Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,420,643, 2013 | 9 | 2013 |
Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,034,815, 2011 | 15 | 2011 |
Compounds and method for treatment of HIV W Danter, C Threlfall, S Guizzetti, J Marin US Patent 9,624,220, 2017 | | 2017 |
Compounds and method for treatment of HIV W Danter, C Threlfall, S Guizzetti, J Marin US Patent 8,987,272, 2015 | 2 | 2015 |
Compounds and method for treatment of HIV W Danter, C Threlfall, S Guizzetti, J Marin US Patent 9,422,282, 2016 | | 2016 |